Deborah Knee

1.8k total citations
21 papers, 1.5k citations indexed

About

Deborah Knee is a scholar working on Molecular Biology, Immunology and Oncology. According to data from OpenAlex, Deborah Knee has authored 21 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Molecular Biology, 9 papers in Immunology and 5 papers in Oncology. Recurrent topics in Deborah Knee's work include Cell death mechanisms and regulation (7 papers), Immune Cell Function and Interaction (4 papers) and T-cell and B-cell Immunology (4 papers). Deborah Knee is often cited by papers focused on Cell death mechanisms and regulation (7 papers), Immune Cell Function and Interaction (4 papers) and T-cell and B-cell Immunology (4 papers). Deborah Knee collaborates with scholars based in United States, Switzerland and China. Deborah Knee's co-authors include Jennifer L. Brogdon, Becker Hewes, Shinichi Takayama, Marc Nasoff, Seth A. Ettenberg, Glenn Dranoff, Yannick Bulliard, Sarah Rue, Quinn L. Deveraux and Nicholas S. Wilson and has published in prestigious journals such as Journal of Biological Chemistry, The Journal of Experimental Medicine and Blood.

In The Last Decade

Deborah Knee

21 papers receiving 1.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Deborah Knee United States 14 756 601 523 134 122 21 1.5k
Ningping Feng United States 23 607 0.8× 451 0.8× 521 1.0× 58 0.4× 72 0.6× 65 1.7k
Kun Yao China 22 693 0.9× 284 0.5× 492 0.9× 81 0.6× 165 1.4× 108 1.9k
Sarah A. Weiss United States 14 768 1.0× 753 1.3× 758 1.4× 75 0.6× 30 0.2× 22 1.8k
Paola Mina‐Osorio United States 19 407 0.5× 222 0.4× 383 0.7× 30 0.2× 53 0.4× 38 1.7k
Caroline Saucier Canada 21 751 1.0× 320 0.5× 412 0.8× 35 0.3× 38 0.3× 37 1.4k
Adam G. Schrum United States 22 506 0.7× 972 1.6× 397 0.8× 16 0.1× 91 0.7× 58 1.7k
Jose F. Ponte United States 16 1.1k 1.4× 110 0.2× 461 0.9× 84 0.6× 215 1.8× 34 1.7k
Weihua Li China 13 1000 1.3× 167 0.3× 289 0.6× 44 0.3× 48 0.4× 42 1.5k
Katsuya Ota Japan 18 557 0.7× 145 0.2× 305 0.6× 49 0.4× 16 0.1× 43 1.1k
F. vom Dorp Germany 24 1.0k 1.3× 237 0.4× 376 0.7× 42 0.3× 20 0.2× 86 1.9k

Countries citing papers authored by Deborah Knee

Since Specialization
Citations

This map shows the geographic impact of Deborah Knee's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Deborah Knee with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Deborah Knee more than expected).

Fields of papers citing papers by Deborah Knee

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Deborah Knee. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Deborah Knee. The network helps show where Deborah Knee may publish in the future.

Co-authorship network of co-authors of Deborah Knee

This figure shows the co-authorship network connecting the top 25 collaborators of Deborah Knee. A scholar is included among the top collaborators of Deborah Knee based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Deborah Knee. Deborah Knee is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Abrisqueta, Pau, Reinhard Marks, Irit Avivi, et al.. (2024). Abstract CT174: A phase 1 study of JBH492, an anti C-C chemokine receptor 7 antibody-drug conjugate (anti-CCR7 ADC), assessing safety and efficacy in lymphoid malignancies. Cancer Research. 84(7_Supplement). CT174–CT174. 3 indexed citations
2.
Ji, Yan, Deborah Knee, Lore Gruenbaum, et al.. (2023). Quantitative systems pharmacology model of GITR‐mediated T cell dynamics in tumor microenvironment. CPT Pharmacometrics & Systems Pharmacology. 12(3). 413–424. 8 indexed citations
3.
Knee, Deborah, Feng Gao, Keith G. Mansfield, et al.. (2022). A Novel Antibody-Drug Conjugate Targeting CCR7 in Hematologic Malignancies. Blood. 140(Supplement 1). 11564–11565. 4 indexed citations
4.
Ji, Yan, Deborah Knee, Xinhui Chen, et al.. (2022). Model‐informed drug development for immuno‐oncology agonistic anti‐GITR antibody GWN323: Dose selection based on MABEL and biologically active dose. Clinical and Translational Science. 15(9). 2218–2229. 6 indexed citations
5.
Knee, Deborah, Becker Hewes, & Jennifer L. Brogdon. (2016). Rationale for anti-GITR cancer immunotherapy. European Journal of Cancer. 67. 1–10. 165 indexed citations
6.
Lau, Janet, Deborah Knee, Christophe Filippi, et al.. (2013). IL-2 Immunotherapy Reveals Potential for Innate Beta Cell Regeneration in the Non-Obese Diabetic Mouse Model of Autoimmune Diabetes. PLoS ONE. 8(10). e78483–e78483. 14 indexed citations
7.
Bulliard, Yannick, Sarah Rue, Seth A. Ettenberg, et al.. (2013). Activating Fc γ receptors contribute to the antitumor activities of immunoregulatory receptor-targeting antibodies. The Journal of Experimental Medicine. 210(9). 1685–1693. 358 indexed citations
8.
Li, Jing, Deborah Knee, Youzhen Wang, et al.. (2008). LBY135, a novel anti‐DR5 agonistic antibody induces tumor cell–specific cytotoxic activity in human colon tumor cell lines and xenografts. Drug Development Research. 69(2). 69–82. 15 indexed citations
9.
Li, Jing, Qingxiu Zhang, Jennifer Johnson, et al.. (2007). Tumor-cell specific cytotoxic activity of LBY135, a novel anti- DR5 agonistic antibody. Cancer Research. 67. 4875–4875. 3 indexed citations
10.
Li, Jing, Betty Tang, Joseph Eckman, et al.. (2007). Antitumor efficacy of LBY135, an anti-DR5 monoclonal antibody, alone or in combination with chemotherapy in human colon tumor cell lines and xenografts. Cancer Research. 67. 4874–4874. 5 indexed citations
11.
Natoni, Alessandro, Marion MacFarlane, Satoshi Inoue, et al.. (2007). TRAIL signals to apoptosis in chronic lymphocytic leukaemia cells primarily through TRAIL‐R1 whereas cross‐linked agonistic TRAIL‐R2 antibodies facilitate signalling via TRAIL‐R2. British Journal of Haematology. 139(4). 568–577. 53 indexed citations
12.
Natoni, Alessandro, Marion MacFarlane, Satoshi Inoue, et al.. (2007). TRAIL signals to apoptosis in CLL cells primarily through TRAIL R-1 whereas cross-linked agonistic TRAIL R-2 antibodies facilitate signalling via TRAIL R-2. Leicester Research Archive (University of Leicester). 42 indexed citations
13.
Wang, Yan, Ingo H. Engels, Deborah Knee, et al.. (2004). Synthetic lethal targeting of MYC by activation of the DR5 death receptor pathway. Cancer Cell. 5(5). 501–512. 131 indexed citations
14.
Wagner, Klaus W., et al.. (2004). Differential Regulation of the TRAIL Death Receptors DR4 and DR5 by the Signal Recognition Particle. Molecular Biology of the Cell. 15(11). 5064–5074. 92 indexed citations
15.
Wagner, Klaus W., et al.. (2003). Activation and Suppression of the TRAIL Death-Receptor Pathway in Chemotherapy Sensitive and Resistant Follicular Lymphoma Cells. Cancer Biology & Therapy. 2(5). 534–540. 8 indexed citations
16.
Knee, Deborah, Barbara A. Froesch, Ulrike A. Nuber, Shinichi Takayama, & John C. Reed. (2001). Structure-Function Analysis of Bag1 Proteins. Journal of Biological Chemistry. 276(16). 12718–12724. 61 indexed citations
17.
Briknarová, Klára, Shinichi Takayama, Lars Brive, et al.. (2001). Structural analysis of BAG1 cochaperone and its interactions with Hsc70 heat shock protein.. Nature Structural Biology. 8(4). 349–352. 127 indexed citations
18.
Takayama, Shinichi, S Krajewski, Maryla Krajewska, et al.. (1998). Expression and location of Hsp70/Hsc-binding anti-apoptotic protein BAG-1 and its variants in normal tissues and tumor cell lines.. PubMed. 58(14). 3116–31. 193 indexed citations
19.
Biederman, Joseph, Stephen V. Faraone, Deborah Knee, & Kerim Münir. (1990). Retrospective assessment of DSM-III attention deficit disorder in nonreferred individuals.. PubMed. 51(3). 102–6. 47 indexed citations
20.
BIEDERMAN, JOSEPH, et al.. (1987). High rate of affective disorders in probands with attention deficit disorder and in their relatives: a controlled family study. American Journal of Psychiatry. 144(3). 330–333. 99 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ningping Feng Breakdown of academic impact, for papers by Kun Yao Breakdown of academic impact, for papers by Sarah A. Weiss Breakdown of academic impact, for papers by Paola Mina‐Osorio Breakdown of academic impact, for papers by Caroline Saucier Breakdown of academic impact, for papers by Adam G. Schrum Breakdown of academic impact, for papers by Jose F. Ponte Breakdown of academic impact, for papers by Weihua Li Breakdown of academic impact, for papers by Katsuya Ota Breakdown of academic impact, for papers by F. vom Dorp
Rankless by CCL
2026